TABLE 3.
Baseline Endometrial Echocomplex (mm) and Mean Change from Baseline Across Trial Visits by Treatment Group
| Placebo n = 103 | ISP n = 121 | P-value | |
|---|---|---|---|
| All participants, baseline a | 2.50 (1.10) | 2.40 (1.00) | 0.82 |
| All participants, change b | −0.95 (0.26) | −0.98 (0.20) | 0.88 |
| Excluding participant with endometrial cancer, change b | −1.09 (0.22) | −1.05 (0.19) | 0.84 |
a
Baseline numbers are median (IQR). Treatment groups compared using Wilcoxon two-sample test.
b
Mean (SE) change from baseline, adjusted for randomization stratum. Treatment groups compared using generalized estimating equations with identity link function and exchangeable correlation structure